Literature DB >> 12926837

A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis.

Yvette Morcos1, Sang Min Lee, Michael C Levin.   

Abstract

The purpose of this study was to examine the roles played by astrocytes in a case of rapidly progressive multiple sclerosis (MS). Within early-active and active lesions, hypertrophic astrocytes played an important role in lesion pathology through the phagocytosis of myelin and axonal debris and through the internalization of other glial cells, including astrocytes. In addition to this critical role, hypertrophic astrocytes, in areas that lack significant inflammation (within the adjacent normal appearing white matter and within late remyelinating lesions) were found to be active in myelin and axonal debris phagocytosis with no evidence of cellular internalization. Hypertrophic astrocytes therefore not only play an important role in the pathogenesis of MS lesions but also exert a continued deleterious effect upon tissue in the absence of significant inflammation. In addition, we found evidence for a significant population of vimentin-positive, glial fibrillary acidic protein (GFAP)-negative, bipolar, astrocyte precursors within the late remyelinating lesions. Their significance is not known but a possible role may include their participation in the successful remyelination of the lesion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926837     DOI: 10.1191/1352458503ms931oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

1.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

2.  Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.

Authors:  Paul D Storer; Jihong Xu; Janet A Chavis; Paul D Drew
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

3.  Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.

Authors:  Gerald Ponath; Sriram Ramanan; Mayyan Mubarak; William Housley; Seunghoon Lee; F Rezan Sahinkaya; Alexander Vortmeyer; Cedric S Raine; David Pitt
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

4.  Mitotic activity of multinucleated giant cells with glial fibrillary acidic protein immunoreactivity in glioblastomas: an immunohistochemical double labeling study.

Authors:  Hiroaki Takeuchi; Kazufumi Sato; Kazunori Ido; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

5.  Impact of Astrocyte Depletion upon Inflammation and Demyelination in a Murine Animal Model of Multiple Sclerosis.

Authors:  Lisa Allnoch; Wolfgang Baumgärtner; Florian Hansmann
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

6.  Astrocytic phagocytosis contributes to demyelination after focal cortical ischemia in mice.

Authors:  Ting Wan; Wusheng Zhu; Ying Zhao; Xiaohao Zhang; Ruidong Ye; Meng Zuo; Pengfei Xu; Zhenqian Huang; Chunni Zhang; Yi Xie; Xinfeng Liu
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.